Morgan Stanley Is Increasing China Overweight, Garner Says
Before it's here, it's on the Bloomberg Terminal.Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Price to Book Ratio4.3872
Price to Sales Ratio5.8468
1 Year Return-6.98%
30 Day Avg Volume110,206,855
Last Dividend Reported0.018737
About Nasdaq Biotechnology Index
The NASDAQ Biotechnology Index is a modified market capitalization-weighted index designed to measure the performance of all NASDAQ stocks in the biotechnology sector. The index was developed with a base value of 200 as of November 1, 1993.